Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 12:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 2,254 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Guided intervention Clear all

Conditions: Cocaine-Related Disorders, Substance-Related Disorders
Interventions: Risperidone, Placebo, Relapse prevention counseling; Drug · Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 60 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 1999
U.S. locations: 1
States / cities: New York, New York

Conditions: Lung Cancer, Metastatic Cancer
Interventions: Cryotherapy (PTC), Prednisone; Procedure · Drug
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years to 120 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2021
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Bursitis
Interventions: Trochanter bursa injections, Ultrasound; Procedure · Device
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Facet Joints; Degeneration, Neuropathy, Neuralgia
Interventions: Cryoablation under image guidance, MRI Seednet Cryotherapy System (Galil Medical); Procedure · Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Esophageal Cancer
Interventions: Near Infrared Imaging; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Domestic Violence
Interventions: Single-session intervention (SSI); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Pancreatic Neoplasm, Pancreatic Neuroendocrine Tumor
Interventions: Clinical Intervention or Procedure, Electronic Health Record Review, Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Pancreas, PEF-ablation of pancreatic cyst; Other · Procedure · Device
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Healthy Lifestyle Behaviors, Depressive/Anxiety Symptoms
Interventions: COPE/Healthy Lifestyles TEEN Program., Healthy Teens Attention Control Program; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 14 Years to 16 Years
Enrollment: 1,219 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Depression, Anxiety
Interventions: IDgenetix Neuropsychiatric Test Panel; Genetic
Lead sponsor: AltheaDx; Industry
Eligibility: 18 Years and older
Enrollment: 579 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 17
States / cities: Rolling Hills, California • San Diego, California • Torrance, California + 13 more

Conditions: Pancreatic Ductal Adenocarcinoma
Interventions: Neoadjuvant Chemotherapy (NAC), Immunotherapy (pembrolizumab), Endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA); Drug · Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Anorexia Nervosa
Interventions: Narrative Medicine (NM) Workshop Series; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 16 Years to 25 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sepsis, Acute Kidney Injury, Septic Shock
Interventions: Subject management guided by NephroCheck® test, Standard of Care; Device · Other
Lead sponsor: BioMérieux; Industry
Eligibility: 21 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Shreveport, Louisiana • Boston, Massachusetts • New York, New York

Conditions: End Stage Liver Disease, Decompensated Cirrhosis of Liver
Interventions: Palliative Care; Other
Lead sponsor: Albert Einstein Healthcare Network; Other
Eligibility: 18 Years to 120 Years
Enrollment: 1,494 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 19
States / cities: Birmingham, Alabama • Phoenix, Arizona • Fresno, California + 15 more

Conditions: Lung Carcinoma
Interventions: Educational Intervention, Interview, Questionnaire Administration; Other
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 50 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Type 1 Diabetes, Family Relations
Interventions: The 3Ms 2.0 Intervention, Educational Attention Control (EAC); Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 10 Years to 14 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Detroit, Michigan • Memphis, Tennessee

Conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neuroblastoma
Interventions: Biopsy Procedure, Bone Marrow Aspiration, Bone Marrow Biopsy, Carboplatin, Clinical Observation, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Magnetic Resonance Imaging, Ultrasound; Procedure · Drug · Other
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 18 Months
Enrollment: 391 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 193
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 147 more

Conditions: Overweight and Obesity
Interventions: Experimental: Web-based only (WO) weight intervention, Experimental: WO plus peer-led discussion board (WD), Experimental: WO & professional email counseling (WE); Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 40 Years to 69 Years · Female only
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Stress, Externalizing Symptoms, Depression Symptoms, Anxiety
Interventions: The Mind in Action, Healthy Topics; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 13 Years to 16 Years
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Basal Cell Carcinoma
Interventions: Optical Coherence Tomography (OCT), Curettage & Desiccation (C&D) Procedure; Device · Procedure
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Social Anxiety
Interventions: iExposure, iExposure plus attention guidance, iExposure plus attention control; Behavioral
Lead sponsor: Palo Alto University; Other
Eligibility: 18 Years and older
Enrollment: 390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor
Interventions: Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT), Photon Emission Tomography / CT (PET/CT), 64Cu-Dotatate, 177Lu-Dotatate; Device · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Prostate Cancer
Interventions: Fine Needle Photoacoustic Probe; Device
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Sleep, Well-Being (Psychological Flourishing)
Interventions: Equa, Coping Control; Behavioral
Lead sponsor: Carnegie Mellon University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 4
States / cities: Notre Dame, Indiana • New York, New York • Pittsburgh, Pennsylvania + 1 more

Conditions: Stroke, Hemiparesis, Upper Extremity Impairments, Stroke Rehabilitation
Interventions: Tele-CPASS, In-person CPASS therapy; Behavioral
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 3
States / cities: El Paso, Texas

Search by objective public record fields.

Early Phase II Trials for Cocaine Medication Development - 1

Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis

Comparison of Ultrasound Guided Versus Blind Corticosteroid Injection for Trochanteric Bursitis

MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine

NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer

Single Session Intervention to Promote Hope

Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms

COPE/Healthy Lifestyles for Teens: A School-Based RCT

Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa

A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis)

Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)

An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial

Family Intervention for Black Teens With Type 1 Diabetes

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Web-Based Weight Loss & Weight Maintenance Intervention for Older Rural Women, Also Known as Women Weigh-in for Wellness

Teenage Health and Wellness Study

Optical Coherence Tomography Guided C&D

iExposure Intervention for Social Anxiety

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe

Cognitive Training for Student Sleep and Wellness

Efficacy of Tele-CPASS Compared to In-person CPASS Therapy for Upper Extremity Motor Recovery